June 25, 2006 Propensity Score Adjustment in Survival Models Carolyn Rutter Group Health Cooperative AcademyHealth, Seattle WA.

Slides:



Advertisements
Similar presentations
The ENCORE Study Cardiovascular Benefits Associated With the DASH Diet Alone and in Combination with Exercise and Weight Reduction in Men and Women with.
Advertisements

Confounding: what it is and how to deal with it Kitty J. Jager¹, Carmine Zoccali 2, Alison MacLeod 3 and Friedo W. Dekker 1,4 1 ERA–EDTA Registry, Dept.
The Application of Propensity Score Analysis to Non-randomized Medical Device Clinical Studies: A Regulatory Perspective Lilly Yue, Ph.D.* CDRH, FDA,
The Burden of Obesity among a National Probability Sample of Veterans Karin Nelson, MD MSHS Assistant Professor Department of Medicine, University of Washington.
1 TennCare Diabetes Program Evaluation Presentation to AcademyHealth Kenton Johnston, MPH, MS, MA June 4, 2007 An Individually-Matched Control Group Evaluation.
Surgery volume and operative mortality: A re-examination using fixed-effects regression Amresh Hanchate, PhD Section of General Internal Medicine Boston.
Cost-sharing for Emergency Care and Unfavorable Clinical Events: Findings from the Safety And Financial Ramifications of ED Copayments (SAFE) Study AcademyHealth.
Adherence to Antidepressant Medications Among Health Plan Members Diagnosed with Major Depression Ayse Akincigil, John R. Bowblis, Carrie Levin, James.
Quality and Use in Managed Care Sarah Hudson Scholle Academy Health Annual Research Meeting Seattle June 26, 2006.
National Scorecard, 2008: Chartpack This Chartpack presents data for all indicators scored in the National Scorecard on U.S. Health System Performance,
Allison Dunning, M.S. Research Biostatistician
Survival Analysis In many medical studies, the primary endpoint is time until an event occurs (e.g. death, remission) Data are typically subject to censoring.
Asthma in Minnesota Slide Set Asthma Program Minnesota Department of Health January 2013.
External validity: to what populations do our study results apply?
Exercise is Medicine: Translational Research in Obesity and Insulin Resistance Alice S. Ryan, Ph.D. Baltimore VA Medical Center University of MD School.
UK Renal Registry 17th Annual Report Figure 5.1. Trend in one year after 90 day incident patient survival by first modality, 2003–2012 cohorts (adjusted.
Carol Coupland Paula Dhiman Tony Arthur Richard Morriss Julia Hippisley-Cox University of Nottingham Garry Barton University of East Anglia Antidepressant.
If we use a logistic model, we do not have the problem of suggesting risks greater than 1 or less than 0 for some values of X: E[1{outcome = 1} ] = exp(a+bX)/
WHITE BLOOD CELL COUNT SECULAR TREND AND MORTALITY: THE BALTIMORE LONGITUDINAL STUDY OF AGING C.Ruggiero; E.J.Metter; A.Cherubini; M.Maggio; R.Sen; S.S.Najjar;
Presentations in this series 1.Introduction 2.Self-matching 3.Proxies 4.Intermediates 5.Instruments 6.Equipoise Avoiding Bias Due to Unmeasured Covariates.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2009.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2011.
Chapter 51 Experiments, Good and Bad. Chapter 52 Experimentation u An experiment is the process of subjecting experimental units to treatments and observing.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2010.
Journal Club Alcohol and Health: Current Evidence July–August 2004.
Cohort Studies Hanna E. Bloomfield, MD, MPH Professor of Medicine Associate Chief of Staff, Research Minneapolis VA Medical Center.
HEAPHY 1 & 2 DIAGNOSTIC James HAYES Fri 30 th Aug 2013 Session 2 / Talk 4 11:33 – 12:00 ABSTRACT To estimate population attributable risks for modifiable.
Covariate Selection for Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research and Quality (AHRQ)
HSTAT1101: 27. oktober 2004 Odd Aalen
Emily O’Brien, Emil Fosbol, Andrew Peng, Karen Alexander, Matthew Roe, Eric Peterson The Obesity Paradox: The Importance for Long-term Outcomes in Non-ST-Elevation.
Diabetes incidence and long-term exposure to air pollution: a cohort study Zorana Jovanovic Andersen ISEE.
Health Care Costs Associated with Chronic Kidney Disease in Patients with Type II Diabetes Zita Shiue, MD Internal Medicine, R3 Chief of Medicine Conference.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2014.
1 Is Managed Care Superior to Traditional Fee-For-Service among HIV-Infected Beneficiaries of Medicaid? David Zingmond, MD, PhD UCLA Division of General.
Association between Systolic Blood Pressure and Congestive Heart Failure in Hypertensive Patients Mrs. Sutheera Intajarurnsan Doctor of Public Health Student.
Cognitive Impairment: An Independent Predictor of Excess Mortality SACHS, CARTER, HOLTZ, ET AL. ANN INTERN MED, SEP, 2011;155: ZACHARY LAPAQUETTE.
Effect of Hypertension and Dyslipidemia on glycemic control among Type 2 Diabetes patients in Thailand Dr. Mya Thandar Dr.PH. Batch 5 1.
Thomas S. Rector, PhD, Inder S. Anand, MD, David Nelson, PhD, Kristine Ensrud, MD and Ann Bangerter, MS CHF QUERI NETWORK November 8, 2007 VA Medical Center,
A role for lipids and statins in breast cancer risk and prevention? Dr. Mieke Van Hemelrijck Senior Lecturer in Cancer Epidemiology 3 August 2015.
Introduction to confounding and DAGs
Article Review Cara Carty 09-Mar-06. “Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of.
Estimating Causal Effects from Large Data Sets Using Propensity Scores Hal V. Barron, MD TICR 5/06.
Association between Systolic Blood Pressure and Congestive Heart Failure Complication among Hypertensive and Diabetic Hypertensive Patients Mrs. Sutheera.
Effect of Hypertension and Dyslipidemia on glycemic control among Type 2 Diabetes patients in Thailand Dr. Mya Thandar DrPH Batch 5 1.
Lecture 9: Analysis of intervention studies Randomized trial - categorical outcome Measures of risk: –incidence rate of an adverse event (death, etc) It.
A Claims Database Approach to Evaluating Cardiovascular Safety of ADHD Medications A. J. Allen, M.D., Ph.D. Child Psychiatrist, Pharmacologist Global Medical.
Hospital racial segregation and racial disparity in mortality after injury Melanie Arthur University of Alaska Fairbanks.
Diabetes Health intelligence Jon Walker Advanced public health analyst Surrey County Council
2007May221 Journal Club for Analysis of Complex Datasets Frost FJ, Petersen H, Tollestrup K, Skipper B. Influenza and COPD mortality protection as pleiotropic,
Clinical Epidemiology and Evidence-based Medicine Unit FKUI – RSCM
1 CONFIDENTIAL – DO NOT DISTRIBUTE ARIES mCRC: Effectiveness and Safety of 1st- and 2nd-line Bevacizumab Treatment in Elderly Patients Mark Kozloff, MD.
Transparency in the Use of Propensity Score Methods
Complex Medical Patients Wayne Katon, MD.  Definition: Illnesses with high prevalence, high comorbidity and bidirectional adverse interactions Examples:
Carina Signori, DO Journal Club August 2010 Macdonald, M. et al. Diabetes Care; Jun 2010; 33,
(ARM 2004) 1 INNOVATIVE STATISTICAL APPROACHES IN HSR: BAYESIAN, MULTIPLE INFORMANTS, & PROPENSITY SCORES Thomas R. Belin, UCLA.
Am J Kidney Dis. 2014;63(6): R3 박세정 /prof. 이태원 Comparative Effectiveness of Early Versus Conventional Timing of Dialysis Initiation in Advanced.
Is it possible to predict New Onset Diabetes After Transplantation (NODAT) in renal recipients using epidemiological data alone? Background NODAT is an.
Matching methods for estimating causal effects Danilo Fusco Rome, October 15, 2012.
Survival time treatment effects
Alcohol, Other Drugs, and Health: Current Evidence July–August 2017
Sofija Zagarins1, PhD, Garry Welch1, PhD, Jane Garb2, MS
Threats to validity in observational studies
Table 1 Characteristics of study population, by pneumococcal vaccination status. From: Prior Pneumococcal Vaccination Is Associated with Reduced Death,
Presenter: Wen-Ching Lan Date: 2018/08/01
Presenter: Wen-Ching Lan Date: 2018/03/28
Determinants of new onset diabetes among hypertensive patients randomised in the ASCOT-BPLA Trial Dr Ajay K Gupta International Centre for Circulatory.
A: Kaplan-Meier estimate of time to first LLA
Clinical outcome after SVR: ANRS CO22 HEPATHER
Physical Activity and Endometrial Cancer Survival
Baseline Demographic Characteristics of Adults With Diagnosed Heart Failure and Eligible to Receive Lipid-Lowering Therapy Alan S. Go, et al.
Presentation transcript:

June 25, 2006 Propensity Score Adjustment in Survival Models Carolyn Rutter Group Health Cooperative AcademyHealth, Seattle WA

June 25, 2006 Outline Propensity Scores: General Ideas Background: depression & mortality among type 2 diabetics Propensity Scores applied to depression & mortality

June 25, 2006 Example: Is depression associated with increased mortality in type 2 diabetics? Underlying question: Does depression increase the risk of death ? Estimate the causal effect of treatment on response exposure outcome Z Y AcademyHealth, Seattle WA

June 25, 2006 Propensity Scores Propensity score: the probability that a person receives treatment, or is exposed, given a set of observed covariates, X. Randomized Study: P(Tx)=0.5, the propensity score is independent of patient characteristics and the distribution of P(Tx) is the same across treatment groups. Observational Study: P(Tx|X) depends on patient characteristics and differs between treatment groups (because Tx is associated with covariates), so that the treated group has a higher propensity for treatment than the untreated group. AcademyHealth, Seattle WA

June 25, 2006 Basic Ideas behind Propensity Score Methods Reduce bias by comparing treated and untreated individuals who have the same propensity for treatment/exposure Key assumption: Strongly Ignorable Treatment Assignment The outcome is conditionally independent of treatment assignment given observed covariates Y P(Z|X) After adjusting for observed covariates, treatment assignment doesnt inform the response. No unmeasured confounders. AcademyHealth, Seattle WA

June 25, 2006 Depression & Mortality among Type 2 Diabetics Depression is common in patients with type 2 diabetes 11% to 15% meet criteria for major depression Depressed diabetic patients tend to have –poorer self-management ( diet, exercise, blood glucose checks ) –more lapses in refilling prescribed medications ( oral hypoglycemics, lipid lowering, anti-hypertensive ) –have cardiac risk factors ( smoking, obesity, sedentary lifestyle ) Studies have linked depression to increased mortality among diabetics, but these used a small number of patients, with medical diagnoses based on self report AcademyHealth, Seattle WA

June 25, 2006 The Pathways Study: a population-based epidemiologic study of over 4000 patients with diabetes enrolled in an HMO. 4262* included in following analyses 513 with major depression 3749 without major depression Katon, Rutter, Simon et al The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care Nov; 28(11): AcademyHealth, Seattle WA Depression & Mortality among Type 2 Diabetics

June 25, year Mortality Outcome All-cause mortality: May 2001(start recruitment) – May /1/2001 – 12/31/2003 (first 31 months): GHC automated health care records + Washington State mortality data 90% of deaths in the State mortality data were in GHC records 1/1/2004 – 4/30/2004 (last 5 months): GHC data alone. Censoring at the end of the study or disenrollment Deaths over a 3-year period: 336 ( 9.0%) in 3749 patients without major depression 60 (11.7%) in 497 patients with major depression

June 25, 2006 Proportional Hazards Model Survivor function: S(t) = Pr(T*>t)=1-F(t) T* event time Hazard function: instantaneous event rate Cox proportional hazards model Unspecified Baseline hazard AcademyHealth, Seattle WA

June 25, 2006 PH Model Results AcademyHealth, Seattle WA * Known confounders: gender, age, race/ethnicity, education Potential behavioral and disease severity confounders &/or mediators: BMI, current smoker, sedentary lifestyle, HbA1c, use of oral hypoglycemics, use of insulin, complications of diabetes, (pharmacy-based) comorbidity measure (excluding depression meds) MethodEstimateSe(estimate)HRP-value Unadjusted <0.02 Minimum Adjustment* <0.001 Full Adjustment

June 25, 2006 Z Depression X Self Care Disease Severity Age, Sex Education Y Death mediator common cause

June 25, 2006 Z X Y mediator common cause

June 25, 2006 Propensity Score Adjustment: 3-Step Process 1.Estimate propensity score 2.Evaluate covariate balance given propensity scores 3.Incorporate propensity score in analyses to synthetically balance the sample Stratification Regression Matching Weighting AcademyHealth, Seattle WA

June 25, 2006 Step 1: Estimate propensity scores Use logistic regression (or other method, e.g., CART) to estimate P(Z=1|X) = i, propensity score logit(Z) =X Focus is on prediction rather than estimation. –Include all potential confounders, but leave out factors related only to the exposure or outcome (Brookhart et al, 2006, AJE) –Include interaction effects as needed –ROC curve can be used to evaluate fit, but doesnt provide insight about appropriate covariates the estimated propensity score for the i th individual AcademyHealth, Seattle WA

June 25, 2006 Step 1: Estimate propensity for depression proc logistic descending; model major=age male smoke obese somecoll sedentary cardio outofcontrol treatint rxrisk2 /outroc=roc; run; Estimated AUC=0.72 Propensity score missing for 6.6% AcademyHealth, Seattle WA

June 25, 2006 Step 1: Estimate propensity for depression proc logistic descending; model major=age male smoke obese somecoll sedentary cardio outofcontrol treatint rxrisk2 + missing value indicators /outroc=roc; run; Estimated AUC=0.72 None missing propensity score AcademyHealth, Seattle WA

June 25, 2006 Propensity Strata AcademyHealth, Seattle WA Strata 1 Strata 2 Strata 3 Strata 4 Strata 5 Strata 6 Strata 7 Not Depressed % % % % 339 9% 146 4% 133 4% % Depressed 27 5% 58 11% 78 15% % 87 17% 67 13% 80 16% % Total853 20% % % % % 213 5% 4262

June 25, 2006 Step 2: Check covariate balance StrataNot depressedDepressedN all Percent Sedentary

June 25, 2006 Step 3: Incorporate Propensity Scores into Proportional Hazards Model 1.Regression: Proportional hazards across different levels of the propensity score 2.Stratification: Allow different baseline hazards across propensity strata 3.Matching: Allow different baseline hazards for each matched pair 4.Weighting: Assume a common baseline hazard, AcademyHealth, Seattle WA

June 25, 2006 Regression-adjustment in the PH model Assume proportionality: check this assumption using Shoenfeld residuals. AcademyHealth, Seattle WA

June 25, 2006 Schoenfeld Residuals Little evidence for non-proportional hazards in propensity scores. Correlation between Schoenfeld-residual and rank-time Depression: 0.02 Propensity: -0.06

June 25, 2006 PH Model Results AcademyHealth, Seattle WA MethodEstimateSe(estimate)HRP-value Min Adj <0.001 Full Adj Regression

June 25, 2006 Stratification-adjustment in the PH model Stratified likelihood j : censoring indicator (1 if death obs) mth strata AcademyHealth, Seattle WA

June 25, 2006 PH Model Results AcademyHealth, Seattle WA MethodEstimateSe(estimate)HRP-value Min Adj <0.001 Fully Adj Regression Stratified

June 25, 2006 Matched Propensity Score Analysis 1.Use the full sample to estimate propensity scores 2.Identify matched pairs based on linear predictor from the propensity model. Matching within ±0.25*SE(X ) is recommended by Rosenbaum & Rubin (1983, 1985) 3.Assess matching: differences between matched and unmatched individuals; balance within matched sample. 4.Analyze data, accounting for matching. AcademyHealth, Seattle WA

June 25, 2006 Matching-adjustment in the PH model only 2/513 depressed excluded Within each matched pair, only the first death contributes to the likelihood leading to additional loss of information. mth pair AcademyHealth, Seattle WA

June 25, 2006 PH model results AcademyHealth, Seattle WA MethodEstimateSe(estimate)HRP-value Min Adj <0.001 Full Adj Regression Stratified Matching

June 25, 2006 AcademyHealth, Seattle WA Weighting-adjustment in the PH model (IPW) Weighted partial Likelihood Function up-weight individuals with unexpected exposure Limits options for handling ties Performs best when weights are estimated (Qi, Wang, Prentice, JASA,2005)

June 25, 2006 PH model results AcademyHealth, Seattle WA MethodEstimateSe(estimate)HRP-value Unadjusted <0.02 Min Adj <0.001 Full Adj Regression Stratified Matching IPW <0.005

June 25, 2006 Z X Y Covariate models Estimate the effect of Z on Y conditional on X

June 25, 2006 IPW does not depend on estimating effects of Y | (Z and X) Z X Y Covariate models Propensity Syntheticall y balances X across Z Propensity models: P(Z|X)

June 25, 2006 Combined Adjustments Regression adjust and weight. AcademyHealth, Seattle WA

June 25, 2006 PH Model Results AcademyHealth, Seattle WA MethodEstimateSe(estimate)HRP-value Min Adj <0.001 Full Adj Regression Stratified Matching IPW <0.005 IPW+Reg <0.005

June 25, 2006 Doubly Robust Regression Model True Propensity Model True NoYes No Yes An approach that is robust to misspecification of the regression model OR the propensity model. AcademyHealth, Seattle WA

June 25, 2006 Doubly Robust Estimators Idea: weighted estimators use only observed outcomes. DR estimators incorporate unobserved outcomes through their expected values. Increase efficiency, increase robustness Adjusted Score Function: indicates observing the assigned (patient selected) treatment weighted score

June 25, 2006 Score Adjustment, i i is an augmentation term that is a function of the regression model, M(Y|X, ) where Y=(, T):

June 25, 2006 Doubly Robust Estimator Expected value is 0 if regression model is true Expected value is 0 if propensity model is true

June 25, 2006 Doubly Robust Estimates Can calculate DR estimates iteratively: 1.Calculate starting values using PH 2.Estimate i via simulation given M(Y|X, ) and current parameter estimates, including baseline hazard (e.g., Nelson-Aalen estimators) 1.Use Newton-Raphson to solve the adjusted score for + TS approx

June 25, 2006 PH model results MethodEstimateSe(estimate)HRP-value Min Adj <0.001 Full Adj Regression Stratified Matching IPW <0.005 DR AcademyHealth, Seattle WA

June 25, 2006 Propensity Adjustment Compared to Inclusion of Covariates Separate models for treatment assignment and outcome. Focus on synthetic balance of sample. Maintain power while adjusting for many covariates –Need about events per independent variable examined Multiple ways to adjust, allowing different assumptions about proportionality of hazards Can no longer make inference about individual covariates

June 25, 2006 Propensity Adjustment for Survival Models Omitting covariates from PH models may result in attenuation of estimates for included covariates (Mitra & Heitjen, Stat in Med, 2006). Covariate adjustment in PH model may reduce bias in estimates of covariate effects ( Lagakos & Shoenfeld, Biometrics, 1984 ) but has little effect on the variance of estimates. ( Anderson & Flemming, Biometrika, 1995 )

June 25, 2006 Propensity Adjustment for Survival Models: Recent Work Sturmer et al. AJE, 2005, Develop a regression- calibration approach to adjust for error in estimated propensity scores. Mitra & Heitjen, Stat in Med, 2006, develop a method for determining the effect an umeasured confounder would need to have to explain observed differences.

June 25, 2006 Propensity Models Additional research: More than two treatment/exposure groups Leon AC, Mueller TI, Solomon DA, Keller MB. 2001, Stat Med. Luellen JK, Shadish WR, & Clark MH. 2005, Evaluation Review, & references therein Imbens G. Biometrika, Continuous treatment/exposure measures AcademyHealth, Seattle WA